| PKG |
Report |
Operating diluted EPS |
BEAT |
pred ~$2.35 vs. cons $2.31 |
MEDIUM |
| PKG |
Report |
Net sales |
IN-LINE |
pred ~$2.52B vs. cons $2.502B |
MEDIUM |
| PKG |
Report |
Implied box volume |
BEAT |
pred ~19.60B sq. ft. vs. cons 19.30B sq. ft. |
MEDIUM |
| PKG |
Guide |
Q3 2026 operating diluted EPS |
BETTER |
guide ~$3.05 vs. cons $2.94 |
LOW |
| PKG |
Guide |
Q3 demand / pricing commentary |
UNKNOWN |
guide: strong volumes and Q3 price realization; no reliable numerical consensus |
MEDIUM |
| PKG |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.0% |
— |
LOW |
| PKG |
Return |
5-day cumulative residual |
+6.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Q3 price realization lifts forward estimates |
LOW |